PATENT CLAIM ANALYSIS

Application Number: 15918308
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["514", "502000"]

Abstract:
The present invention discloses a novel form of ferric organic compounds, including a form of ferric citrate, which are soluble over a wider range of pH, and which have a large active surface area. The ferric organic compounds of the present invention can be delivered effectively by oral route with better delivery to treat patients suffering from hyperphosphatemia, metabolic acidosis and other disorders responsive to ferric organic compound therapy.

Claim (Index 86):
The method of  claim 82 , wherein the therapeutically effective amount is about 3 to 6 grams per day.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 90.0
- Lexical Diversity: 1.44231
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15143987', '14011357', '14011325', '11206981', '14502774']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7868608679515797
- 35 USC 102 Novelty (BERT): 0.5278920619346092
- Combined Prediction Score: 0.7609639873498827
- Mean Citation Score: 329.0986420000001
- Max Citation Score: 344.35843
- Similarity Product: 274.164360614227

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test